Metavasi Capital’s Salesforce CRM Stock Holding History

Metavasi Capital’s Portfolio CRM Stock Details CRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-25,000	Closed	-$4.99M	–	29
2023 Q1	$4.99M	Buy	+25,000	New	+$4.22M	3.72%	9

Other funds holding CRM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Metavasi Capital's CRM Position: Q2 2023 in Review

Metavasi Capital sold out of Salesforce (CRM) in Q2 2023, closing a stake of 25,000 shares — an estimated $4.99M sold.

Metavasi Capital first reported a position in CRM in Q1 2023 and held it in 1 quarter. The position peaked at $4.99M in Q1 2023. 2,293 funds tracked by Wall St. Rank hold CRM as of Q2 2023.

Metavasi Capital reported no remaining Salesforce position as of Q2 2023 after selling out during the quarter.
Metavasi Capital sold 25,000 Salesforce shares in Q2 2023, an estimated $4.99M.
Metavasi Capital first reported a position in Salesforce in Q1 2023 and held it in 1 quarter.
Metavasi Capital's Salesforce position peaked at $4.99M in Q1 2023.
2,293 funds tracked by Wall St. Rank held Salesforce as of Q2 2023.

Based on Metavasi Capital's 13F filing for Q2 2023, filed 14 Aug 2023.